Receptor-targeted metalloradiopharmaceuticals. Final technical report
Copper (II) and platinum (II) coordination complexes were prepared and characterized. These complexes were designed to afford structural homology with steroidal and non-steroidal estrogens for possible use as receptor-targeted radiopharmaceuticals. While weak affinity for the estrogen receptor was detectable, none would appear to have sufficient receptor-affinity for estrogen-receptor-targeted imaging or therapy.
- Research Organization:
- Purdue Research Foundation, West Lafayette, Indiana, USA (US)
- Sponsoring Organization:
- USDOE Office of Energy Research (ER) (US)
- DOE Contract Number:
- FG02-97ER62340
- OSTI ID:
- 765624
- Resource Relation:
- Other Information: PBD: 22 Mar 2000
- Country of Publication:
- United States
- Language:
- English
Similar Records
Targeted Radiotherapy of Estrogen Receptor Positive Tumors
Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast. Technical progress report, February 1, 1992--January 31, 1993
Non-carrier-added 186, 188Re labeled 17a-ethynylestradiol : a potential breast cancer imaging and therapy agent
Technical Report
·
Thu Aug 31 00:00:00 EDT 2006
·
OSTI ID:765624
Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast. Technical progress report, February 1, 1992--January 31, 1993
Technical Report
·
Sat Aug 08 00:00:00 EDT 1992
·
OSTI ID:765624
Non-carrier-added 186, 188Re labeled 17a-ethynylestradiol : a potential breast cancer imaging and therapy agent
Conference
·
Mon Jan 01 00:00:00 EST 2001
·
OSTI ID:765624
+2 more